Inteliphage
Board
4 directors, 1 in day-to-day management, 1 auditor, last change in February 2026Deed of 10-02-2026Reappointment: Deloitte réviseur d'entreprises SRL (statutory auditor)General meeting of 20-11-2024
Chair of the board and director
chair of the board appointed by deed of 12-12-2025
director current term since 23-06-2025
listed in the 2025 annual accounts, filed on 13-07-2026
CENTIVIA
Director and managing director, permanent representative Charles PERRARD
director since 23-06-2025
managing director appointed by deed of 12-12-2025
listed in the 2025 annual accounts, filed on 13-07-2026
Director
since 24-12-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 13-07-2026
Statutory auditor, permanent representative Julie Delforge
current term since 20-11-2024
3-year term from 2026
listed in the 2025 annual accounts, filed on 13-07-2026
- CENTIVIA
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Les décisions de l'organe d'administration sont constatées dans des procès-verbaux qui sont signés par le président de la réunion et les…”deed of 24-06-2021
Permanent representatives 1
Mandates through the years
13 names, the dashed line is todayAnjac SAS
Director
Director
CAEYMAEX Emmanuel Xavier Anne Paul Marie
Director, Chair of the board
Director, Chair of the board
CENTIVIA
Director, Managing director
Director, Managing director
RAUEL Sylvie
Director
Director
Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises
Statutory auditor
Statutory auditor
Guillaume de Viron
Director
Director
Jérôme Majoie
Chair of the board
Chair of the board
Mehdi EL GLAOUI
Director
Director
VANWEZER Gunther
Managing director
Managing director
VESALE INVEST, SLU
Director
Director
ANJAC
Director
Director
Olivier POSWICK
Director
Director
Vesale Pharma International
Sole director
Sole director
LeadershipBoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
- Anjac SAS
- Director, since before 31-12-2022
- CAEYMAEX Emmanuel Xavier Anne Paul Marie
- Director, since before 31-12-2023
- Chair of the board, from 23-06-2025 to date
- CENTIVIA
- Director, from 23-06-2025 to date
- Managing director, appointed by deed of 12-12-2025, still in office
- RAUEL Sylvie
- Director, from 24-12-2025 to date
- Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises
- Statutory auditor, since before 31-12-2021
- Guillaume de Viron
- Director, from before 31-12-2021 to 23-06-2025
- Jérôme Majoie
- Director, from before 31-12-2021 to 23-06-2025
- Chair of the board, appointed by deed of 04-04-2022, until 23-06-2025
- Mehdi EL GLAOUI
- Director, from before 31-12-2021 to 23-06-2025
- VANWEZER Gunther
- Director, from before 31-12-2022 to 23-06-2025
- Managing director, appointed by deed of 21-09-2023, until 23-06-2025
- VESALE INVEST, SLU
- Sole director, from 01-06-2021 to 30-04-2024
- Managing director, appointed by deed of 04-04-2022, until 21-09-2023
- Director, until 22-05-2024
- ANJAC
- Director, appointed by deed of 10-07-2023, no longer listed in the 2025 annual accounts
- Olivier POSWICK
- Director, from before 31-12-2021 to 10-07-2023
- Vesale Pharma International
- Sole director, until 24-06-2021
Control
Shareholder
VESALE INVEST,SLU
This company
Inteliphage
Equity €3.2m
Loss €2.0m in 2025
Capital
- Contribution
- €3,877,730
- Shares
- 16,112,914 in the deed of 24-06-2021 and 3 later capital increases
- Contribution per share
- €0.24
- Equity per share
- €0.20 in 2025
- Source
- 2025 annual accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 24-06-2021 (in French)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 directordeed of 24-06-2021 (in French)
- Power of attorneyA power of attorney lets someone perform specific acts on the company's behalf.
- “Quentin de Bournonville”“Valentine Bonamis”deed of 10-02-2026 (in French)
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Tous pouvoirs article 2:87 CSA sans autorisation spéciale AG;AG peut limiter à majorité simple, par AG,le cas échéant soumise au président…”deed of 24-06-2021 (in French)
Shareholders
Stated in the deed
deed of 24-06-2021 ↗
- VESALE INVEST,SLU all shares
Capital transactions
Capital over time
- 09-01-2026 Capital increase of €2,721,130 · 5,650,414 new shares · in kind
- 09-01-2026 Capital increase of €50,000 · 62,500 new shares at €0.80 per share · in cash
- 09-01-2026 Capital increase of €400 · 400,000 new shares
- 24-06-2021 Capital stated in the deed · 10,000,000 shares